Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:758-765
Published online before print September 19, 2005, doi: 10.1161/01.HYP.0000186240.81996.57
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v47,pe9)
Right arrow Correction (v47,pe9)
Right arrow All Versions of this Article:
46/4/758    most recent
01.HYP.0000186240.81996.57v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, S. T.
Right arrow Articles by Boerwinkle, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, S. T.
Right arrow Articles by Boerwinkle, E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*SNP
*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*HYDROCHLOROTHIAZIDE
*SODIUM
Related Collections
Right arrow Clinical genetics
Right arrow Clinical Studies
Right arrow Other Treatment
Right arrowRelated Article

(Hypertension. 2005;46:758.)
© 2005 American Heart Association, Inc.


Original Articles

WNK1 Kinase Polymorphism and Blood Pressure Response to a Thiazide Diuretic

Stephen T. Turner; Gary L. Schwartz; Arlene B. Chapman; Eric Boerwinkle

From the Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn (G.L.S., S.T.T.); Renal Division, Emory University, Atlanta, Ga (A.B.C.); and Institute of Molecular Medicine and Human Genetics Center, University of Texas Health Sciences Center, Houston (E.B.).

Correspondence to Stephen T. Turner, MD, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail turner.stephen{at}mayo.edu

Single nucleotide polymorphisms (SNPs) in genes encoding or influencing renal sodium transport systems were investigated as potential predictors of blood pressure (BP) response to a thiazide diuretic. A sample of 585 adults with essential hypertension (30 to 59.9 years of age; 50% blacks; 47% women) were treated with hydrochlorothiazide for 4 weeks (25 mg daily, orally) to determine office BP responses. Ambulatory BP responses were measured in a subset of 228 subjects. After adjustment for ethnicity, sex, age, and waist-to-hip ratio, 3 SNPs in WNK1 (rs2107614, rs2277869, and rs1159744), encoding a lysine-deficient protein kinase that regulates thiazide-sensitive sodium-potassium cotransport, made statistically significant contributions to predicting ambulatory BP responses, accounting for 2% to 4% of variation in systolic and diastolic responses (P<0.05). SNPs in the ß2-adrenoceptor (rs2400707) and the epithelial sodium channel {gamma}-subunit (rs5723 and rs5729) were associated with similar magnitude of variation in ambulatory systolic BP response (P=0.028) or office diastolic BP response (P<0.05), respectively. However, SNPs evaluated in the furosemide-sensitive sodium-potassium chloride cotransporter, potassium inwardly rectifying channel, chloride channel, thiazide-sensitive sodium chloride cotransporter, epithelial sodium channel ß-subunit, and the mineralocorticoid receptor were not associated with significant variation in ambulatory or office BP responses. Polymorphisms in genes regulating renal sodium transport, in particular WNK1, predict interindividual differences in antihypertensive responses to hydrochlorothiazide.


Key Words: polymorphism • genetics • diuretics • blood pressure


Related Article:

Corrections
Hypertension 2006 47: e9-e10. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
M. D. Tobin, N. J. Timpson, L. V. Wain, S. Ring, L. R. Jones, P. M. Emmett, T. M. Palmer, A. R. Ness, N. J. Samani, G. D. Smith, et al.
Common Variation in the WNK1 Gene and Blood Pressure in Childhood: The Avon Longitudinal Study of Parents and Children
Hypertension, November 1, 2008; 52(5): 974 - 979.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Richardson and D. R. Alessi
The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway
J. Cell Sci., October 15, 2008; 121(20): 3293 - 3304.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. T. Turner, K. R. Bailey, B. L. Fridley, A. B. Chapman, G. L. Schwartz, H. S. Chai, H. Sicotte, J.-P. Kocher, A. S. Rodin, and E. Boerwinkle
Genomic Association Analysis Suggests Chromosome 12 Locus Influencing Antihypertensive Response to Thiazide Diuretic
Hypertension, August 1, 2008; 52(2): 359 - 365.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Manunta, G. Lavery, C. Lanzani, P. S. Braund, M. Simonini, C. Bodycote, L. Zagato, S. Delli Carpini, C. Tantardini, E. Brioni, et al.
Physiological Interaction Between {alpha}-Adducin and WNK1-NEDD4L Pathways on Sodium-Related Blood Pressure Regulation
Hypertension, August 1, 2008; 52(2): 366 - 372.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P.-a. B. Shih and D. T. O'Connor
Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity
Hypertension, June 1, 2008; 51(6): 1456 - 1464.
[Full Text] [PDF]